Clinical Study of the RheOx Bronchial Rheoplasty System

Recruiting

35 years - 99 years

All

Phase N/A

12 participants needed

1 Location

Brief description of study

Prospective, randomized, parallel group, double-blind, concurrently controlled, multi-center clinical trial following patients to 2 years to assess the safety and effectiveness the treatment of the symptoms of chronic bronchitis in adult COPD patients with moderate to severe chronic bronchitis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Chronic Bronchitis,COPD
Age: 35 years - 99 years
Gender: All

Male and Female, Age 35 or older, Has chronic bronchitis

Updated on 04 Aug 2024. Study ID: 848997

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Clinical Study of the RheOx Bronchial Rheoplasty System in Treating the Symptoms of Chronic Bronchitis (RheSolve)

Brief description of study

Eligibility of study

Find a site

Interested in the study